According to XBiotech's latest financial reports the company has ยฃ0.13 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | ยฃ0.13 B | -12.36% |
2023-12-31 | ยฃ0.15 B | -12.66% |
2022-12-31 | ยฃ0.17 B | 2.39% |
2021-12-31 | ยฃ0.17 B | 0.82% |
2020-12-31 | ยฃ0.17 B | -68.04% |
2019-12-31 | ยฃ0.54 B | 4271.71% |
2018-12-31 | ยฃ12.46 M | -46.97% |
2017-12-31 | ยฃ23.5 M | -15.5% |
2016-12-31 | ยฃ27.81 M | -54.73% |
2015-12-31 | ยฃ61.44 M | 66.86% |
2014-12-31 | ยฃ36.82 M | 738.47% |
2013-12-31 | ยฃ4.39 M | 70.34% |
2012-12-31 | ยฃ2.57 M |